The Childhood Cancer Survivorship, Treatment, Access, and Research Act is one of the most significant pediatric cancer research bills to be passed. It resulted in an increase in childhood cancer research by encouraging the maintenance of up-to-date data on all children, teens, and young adults with cancer. It also supported the creation of a national pediatric cancer registry and focused attention on the late effects of cancer that continue to affect children even after they are in remission. This act mandated that a pediatric oncologist would have to be included in the National Cancer Advisory Board as well.
On top of that, it allocated $30 million in funding towards childhood cancer research (to be distributed in increments from 2019 to 2023). It is important we continue to show support for this act as it is a huge stepping stone towards achieving the research and funding these children deserve!
Comments